Medicare Enrolled

Melissa Cyr

Hematology & Oncology · Lyndora, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
350 HANSEN PLZ, Lyndora, PA 16045
7242836184
Registered in NPPES since 2005
NPI: 1780686212 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Cyr from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Cyr? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Cyr

Melissa Cyr is a hematology & oncology specialist in Lyndora, PA, with 21 years of NPI registration. Based on federal Medicare data, Cyr performed 3,520 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Cyr received a total of $1,374 from 21 pharmaceutical and/or device companies across 72 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Cyr is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years of NPI registration ▲ Top 19% volume in PA $1,374 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
3,520
Medicare services
Top 19% in PA for hematology & oncology
Not available
Unique patients (not deduplicated)
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
1,060 $0 $1
Injection, granisetron hydrochloride, 100 mcg 790 $0 $3
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
346 $8 $41
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
338 $92 $216
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
275 $132 $288
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
142 $96 $754
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
100 $10 $69
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
99 $22 $100
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
78 $46 $223
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
74 $1 $4
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
57 $62 $145
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
41 $61 $195
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
38 $38 $108
Normal saline infusion, 1000 cc
Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution.
28 $2 $4
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
26 $133 $522
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
17 $126 $332
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
11 $43 $89
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
9.9% high complexity
57.5% medium
32.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,374
Total received (2018-2024)
Avg $343/year across 4 years
Bottom 45% in PA for hematology & oncology
21
Companies
72
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,151
2023
$173
2021
$37
2018
$12

Payments by company (2024)

Novartis Pharmaceuticals Corporation
$301
E.R. Squibb & Sons, L.L.C.
$189
PFIZER INC.
$100
ARRAY BIOPHARMA INC
$100
Celgene Corporation
$94
Lilly USA, LLC
$76
Daiichi Sankyo Inc.
$49
Takeda Pharmaceuticals U.S.A., Inc.
$42
Rigel Pharmaceuticals, Inc.
$38
Acrotech Biopharma Inc.
$26
ADC Therapeutics America, Inc.
$24
Merck Sharp & Dohme LLC
$22
Janssen Biotech, Inc.
$21
Genmab U.S., Inc.
$20
AstraZeneca Pharmaceuticals LP
$19
Eisai Inc.
$16
GlaxoSmithKline, LLC.
$14
Top 3 companies account for 51.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$425
E.R. Squibb & Sons, L.L.C.
$200
ARRAY BIOPHARMA INC
$116
PFIZER INC.
$100
Celgene Corporation
$94
Lilly USA, LLC
$76
Daiichi Sankyo Inc.
$49
Takeda Pharmaceuticals U.S.A., Inc.
$42
Rigel Pharmaceuticals, Inc.
$38
Amgen Inc.
$32
Acrotech Biopharma Inc.
$26
ADC Therapeutics America, Inc.
$24
Merck Sharp & Dohme LLC
$22
Janssen Biotech, Inc.
$21
Genmab U.S., Inc.
$20
AstraZeneca Pharmaceuticals LP
$19
Eisai Inc.
$16
GlaxoSmithKline, LLC.
$14
Acrotech Biopharma LLC
$14
Merck Sharp & Dohme Corporation
$12
Gilead Sciences, Inc.
$12
Top 3 companies account for 54.0% of all-time payments
Associated products mentioned in payments ›
ALUNBRIG · AUGTYRO · BELEODAQ · BRAFTOVI · CARVYKTI · Fabhalta · IBRANCE · IMFINZI · INJECTAFER · INLYTA · KEYTRUDA · KISQALI · Kyprolis · LORBRENA · Lenvima · OJJAARA · OPDIVO · PADCEV · PIQRAY · PLUVICTO · PROMACTA · REBLOZYL · Rezlidhia · SCEMBLIX · TASIGNA · Tivdak · VERZENIO · Vanflyta · XALKORI · XTANDI
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Lyndora?
Compare hematology & oncology specialists in the Lyndora area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
26
County median income
$86,775
Nearest hospital to ZIP centroid (approximate)
INDEPENDENCE HEALTH SYSTEM BUTLER MEMORIAL HOSPITA
4.2 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Cyr is a clinical cardiology specialist, with above-average Medicare volume (top 19% in PA), with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Cyr experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Cyr performed 1,060 dexamethasone injection (steroid) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Cyr receive payments from pharmaceutical companies?
Yes. Cyr received a total of $1,374 from 21 companies across 72 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Cyr's costs compare to other hematology & oncology specialists in Lyndora?
Cyr's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Cyr) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →